Dr Guibin Li, MD | |
7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315-8001 | |
(616) 267-7668 | |
Not Available |
Full Name | Dr Guibin Li |
---|---|
Gender | Female |
Speciality | Geriatric Medicine |
Experience | 41 Years |
Location | 7751 Byron Center Ave Sw Ste C, Byron Center, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578733325 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | 4301091705 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ohio State University State Health System | Columbus, OH | Hospital |
Spectrum Health | Grand rapids, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
SCIENTISTS in the UK and India have observed a "significant" lack of 'editing' in microRNAs in brain tissue of brain cancer patients.
› Verified 3 days ago
Entity Name | Spectrum Health Primary Care Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
SCIENTISTS in the UK and India have observed a "significant" lack of 'editing' in microRNAs in brain tissue of brain cancer patients.
› Verified 3 days ago
Entity Name | Reed City Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831253798 PECOS PAC ID: 6406740695 Enrollment ID: O20040210000104 |
News Archive
Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
SCIENTISTS in the UK and India have observed a "significant" lack of 'editing' in microRNAs in brain tissue of brain cancer patients.
› Verified 3 days ago
Entity Name | Spectrum Health United |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457304495 PECOS PAC ID: 6305836487 Enrollment ID: O20040612000087 |
News Archive
Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
SCIENTISTS in the UK and India have observed a "significant" lack of 'editing' in microRNAs in brain tissue of brain cancer patients.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Guibin Li, MD 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Dr Guibin Li, MD 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315-8001 Ph: (616) 267-7668 |
News Archive
Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
SCIENTISTS in the UK and India have observed a "significant" lack of 'editing' in microRNAs in brain tissue of brain cancer patients.
› Verified 3 days ago
Iris Boettcher, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Byron Center Ave Sw, Suite C, Byron Center, MI 49315 Phone: 616-776-7430 | |
Dr. Stacy Walton Goldsholl, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2745 Railside Ct Sw, Byron Center, MI 49315 Phone: 910-297-4552 | |
Mary Beth Tupper, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 7751 Byron Center Ave Sw, Suite C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Carlos Orval Weiss, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Dr. Michelle Marie Barton, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Angela R Andrews, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2373 64th St Sw, Suite 1300, Byron Center, MI 49315 Phone: 616-685-1350 Fax: 616-261-7191 |